Analyst Reco. Nuvectis Pharma, Inc.

Equities

Market Closed - Nasdaq Other stock markets 20:59:48 04/06/2024 BST			5-day change	1st Jan Change
6.5 ^USD	-0.61%		-1.22%	-22.06%

05-07	Nuvectis Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-08	Nuvectis Pharma's Nxp900 Demonstrates Robust Activity in Non-Small Cell Lung Cancer Cell Lines	CI

Ladenburg Thalmann Initiates Nuvectis Pharma at Buy with $21 Price Target	13/07/22	MT
HC Wainwright Initiates Nuvectis Pharma at Buy With $14 Price Target	02/03/22	MT

No results for this search